以下文章来源于36氪研究院 ，作者36氪研究院 硬件迭代加速， 人形机器人蓄力规模突破。 来源｜ 36氪研究院（ID：kr_research） 封面来源 ｜ IC photo 当前，在政策引领、技术突破与市场需求的共振驱动下 ， 中国具身智能产业 正 迈入快速发展 的 新阶段 。 在此背景下， 资本市场 布局也日益活跃。 公开资料数据显示， 2025年前11个月具身智能产业融资额达到334.73亿元，是2024年同期的4倍；截至2025年 12月21日，全年融资事件超305起，总额超过380亿元，参与的投资机构数量超过600家 。 资本的密集涌入，充分印证了产业发展 的 潜力与市场信心 。这种信心，根植于社会经济发展中持续涌现的明确而迫切的替代需求。 36氪研究院 . 专注于一二级市场及新经济领域的研究与咨询 随着人口老龄化加剧与劳动力结构性短缺等问题持续凸显，社会对能够替代人工、承担高风险任务并提升产线效率的智能化解决方案需求日益迫切。传统 自动化设备受限于固定场景与预设程序，难以适应柔性制造、人机协作等动态复杂环境，产业升级面临核心瓶颈。为突破这一局限， 以人形机器人为代 表的具身智能正在加速演进，逐步形 ...

Group 1 - The rapid evolution and application of artificial intelligence and cutting-edge technologies are causing societal adaptation challenges, leading to feelings of uncertainty among people [1][2] - The focus of technological advancement should be human-centered, with an emphasis on shaping a better future through technology by 2030 [2] Group 2 - The "third transformation" of human life aims to extend healthy lifespan rather than just lifespan, with significant implications for global health and economy [3][5] - Human life expectancy has doubled over the past century, but the growth rate has significantly slowed down, with some regions experiencing stagnation or decline [4] - By 2030, the quality of life is projected to be a major focus, with non-communicable diseases potentially costing the global economy up to $47 trillion if not addressed [5] Group 3 - Advances in gene therapy and artificial intelligence are expected to play crucial roles in extending healthy lifespan, with technologies like CRISPR and AI enhancing medical capabilities [9][17] - Clinical breakthroughs in preventive gene therapy and RNA therapies are showing promise in treating chronic diseases effectively [10][12] - Epigenetic reprogramming is emerging as a potential method to reverse aging, with ongoing research aiming for clinical trials by 2026 [15] Group 4 - Artificial intelligence is set to enhance medical efficiency and understanding of human health, with applications in drug development, disease screening, and personal health management expected to yield significant results by 2030 [17][18] - AI is accelerating drug development processes, reducing timelines from years to months, and improving the success rates of new treatments [18][19] Group 5 - The development of exoskeleton technology is enhancing human physical capabilities, with applications in medical rehabilitation, industrial safety, and personal use expected to expand significantly [24][25] - Innovations in exoskeletons are making them more adaptable and user-friendly, with advancements in sensor technology and materials [28][30] Group 6 - The eVTOL market is projected to grow significantly, with advancements in battery technology and noise reduction strategies being critical for its acceptance and integration into urban transportation [31][32] - The evolution of drones into autonomous aerial robots is enhancing their capabilities for both consumer and industrial applications [34] Group 7 - The development of brain-computer interfaces (BCIs) is transforming the treatment of neurological conditions and enhancing human capabilities, with both invasive and non-invasive technologies showing promise [51][54] - BCIs are moving from experimental to standard treatment options for conditions like paralysis, with significant advancements in technology and regulatory approval processes [52][53]

文｜富充 编辑｜苏建勋 具身智能产业的热度蔓延至机器人租赁市场，让互联网老兵们也"坐不住"了。 《智能涌现》独家获悉，阿里"中供铁军"首任校长、阿里B2B销售培训体系参与建立者李立恒，与另一 位阿里系"三板斧"负责管理培训业务的王明峰（天相）将入职机器人租赁平台擎天租，分别出任总裁、 首席战略官。 擎天租平台发布于2025年12月，并于2026年1月15日披露种子轮融资。该轮次由高瓴创投领投，复星创 富等机构跟投。爱企查数据显示，智元机器人持有擎天租55%的股权，飞阔科技持有15%股权。飞阔科 技成立于2024 年，聚焦机器人在文旅商演、商业导览等实际场景中的落地部署与运营。 △擎天租可以选择不同品牌和形态的机器人，图片：产品截图 平台数据显示，上线三周后，擎天租注册用户数已突破20万，日均租赁订单稳定在200单以上。 但"数据好看"和"生意成立"之间，往往隔着一整条交付链路： 订单是否来自真实复购而非补贴刺激？ 作为租赁平台，擎天租提供不同品牌、型号的机器人出租，可选品牌已包括加速进化、宇树、智元、众 擎、灵初智能、逐际动力等。用户可以根据需求选择年会、网红直播、开业等不同场景，各场景对应不 同型号与价格的 ...

Core Insights - The article emphasizes the rapid evolution and application of artificial intelligence and cutting-edge technologies across various fields, urging a human-centered approach to technological advancement [3][4][5]. Group 1: Human Life's "Third Transformation" - Extending Healthy Lifespan - Human life expectancy has doubled over the past century, with significant improvements attributed to public health, antibiotics, and vaccines [7]. - Recent research indicates a dramatic slowdown in the growth rate of life expectancy, with the average increase dropping to below 0.25 years per decade in the last 30 years [8]. - A shift is occurring from merely extending lifespan to enhancing healthspan, which is the period of life spent in good health, with potential economic implications of up to $47 trillion in costs from non-communicable diseases by 2030 [9]. Group 2: Programmable Life - Gene Therapy - Gene therapy is moving towards optimizing the "life code," with advancements in CRISPR technology and delivery systems expected to mature by 2030 [11]. - Clinical breakthroughs in preventive gene therapy, such as Verve Therapeutics' treatment for cardiovascular disease, show promising results with significant reductions in LDL-C levels [12]. - The success of personalized CRISPR therapy in curing a fatal metabolic disease in a patient highlights the potential of gene therapy [14]. Group 3: Health Planning - AI Enhancing Medical Efficiency - AI is set to revolutionize drug development, disease screening, and personal health management by 2030, significantly reducing the time and cost associated with traditional drug development [21]. - AI combined with multi-omics technology is facilitating faster and more accurate disease screening, with notable advancements in cancer detection [23]. - Aging clock technology is evolving, enabling precise monitoring of aging processes and identifying underlying causes of aging [25]. Group 4: Enhancing Physical Capability - Exoskeleton Technology - Exoskeleton technology is advancing to enhance human physical capabilities, with applications in medical rehabilitation, industrial safety, and personal use [30]. - In the medical field, exoskeletons are evolving from mere mobility aids to intelligent devices that promote neurological recovery [31]. - Consumer-grade exoskeletons are expected to become popular for outdoor activities, significantly improving mobility for users [32]. Group 5: Flying Technology - eVTOL Development - The eVTOL market is projected to reach $41 billion in China by 2040, with significant advancements in battery technology expected to triple flight ranges [37]. - Noise reduction technologies are being explored to enhance social acceptance of eVTOLs, with strategies like "noise corridors" being implemented [38]. - The evolution of drones into aerial robots is enhancing capabilities in both consumer and industrial applications, with significant advancements in autonomous operations [40]. Group 6: Brain-Machine Interfaces - A New Era of Interaction - Brain-machine interfaces (BCIs) are transitioning from experimental therapies to standard treatment options for conditions like paralysis, with companies like Neuralink leading the way [61]. - Non-invasive BCIs are emerging, allowing for enhanced human-computer interaction, with applications in consumer technology [63]. - The integration of BCIs with AI could redefine human-AI collaboration, raising ethical considerations regarding privacy and data protection [64].

Investment Rating - The industry investment rating is "Positive" and maintained [7] Core Insights - Tesla's humanoid robot Optimus is expected to be available for public sale by the end of 2027, marking a significant step towards commercialization in the humanoid robotics sector [2][4] - The report suggests focusing on the entire robotics supply chain, particularly on 1) suppliers of the robot "brain," 2) software-related companies for robot operating systems, and 3) suppliers of components for Tesla's Optimus [2][11] Summary by Sections Event Description - On January 22, during the World Economic Forum, Tesla CEO Elon Musk announced that the humanoid robot Optimus will be available for public sale by the end of 2027 [4] Market Performance - Tesla's Optimus V3 is anticipated to be released in Q1 of this year, with plans for mass production to begin by the end of 2026, aiming for an annual production capacity of 1 million units, eventually scaling up to 10 million units [11] - The domestic humanoid robot industry in China is also expected to see significant growth, with over 140 companies and more than 330 humanoid robot products expected by 2025 [11] Commercialization Progress - The humanoid robot industry is at a critical turning point for commercialization, with Tesla's Optimus already performing basic tasks in factories and expected to complete complex assembly and quality inspection tasks by the end of 2026 [11] - The production line for Optimus has begun operations, with the mass-produced version potentially priced as low as $20,000, which could enhance its application in more complex scenarios [11]

Core Insights - The article emphasizes the upcoming release of Optimus V3, which is expected to exceed performance expectations and has a production plan set for the end of 2026 [1][2] - Tesla's production capacity for Optimus is projected to reach 1 million units annually, with initial production starting at the Fremont factory [1] - The T-chain companies are currently experiencing a downward trend, but this is within expected parameters as they await further developments related to Optimus [3][4] Production and Capacity Planning - Optimus V3 is set to begin production in Q1, with a target of 2 units per week in January, increasing to 10 units in February, and reaching 2,000 units by June [2] - Future production in Texas aims for a capacity of 10 million units annually, indicating significant scaling potential for Tesla's robotics division [2] Market Trends and Company Performance - The T-chain companies have shown mixed performance, with some experiencing notable gains due to successful communications in North America [4][5] - Key companies within the T-chain, such as WX, FS, and KS, have reported positive developments and have seen stock price increases as a result [4] - New technologies and core suppliers are also gaining traction, with several companies entering the RFQ stage, indicating a healthy pipeline for future projects [5] Future Outlook - The article suggests that as the release of Optimus V3 approaches, the focus on core T-chain companies will intensify, leading to a more concentrated investment landscape [5][6] - The overall sentiment is that the market is preparing for a significant shift as Optimus V3 is unveiled, with expectations for renewed interest and investment in the robotics sector [6]

Core Viewpoint - Tesla is shifting its focus from electric vehicles to robotics, planning to invest $20 billion this year to support this transformation, indicating a significant pivot in its business strategy [1][2]. Group 1: Financial Performance and Investment Plans - Tesla's capital expenditure decreased by 24% to $8.6 billion last year, but it is projected to more than double to over $20 billion by 2026 as the company transitions towards artificial intelligence and robotics [1][3]. - The automotive revenue, which constitutes about 70% of Tesla's business, is expected to decline by 10% in 2025 due to the lack of new electric vehicle models and increased competition, particularly from BYD in China and Volkswagen and BMW in Europe [2]. Group 2: Product Development and Future Vision - Tesla plans to end production of the Model S and Model X, which accounted for less than 3% of total deliveries last year, to repurpose the Fremont factory for producing the Optimus robot [2][4]. - Elon Musk envisions that Optimus could eventually make Tesla a $25 trillion company, with 80% of its value derived from robotics [2]. Group 3: Technological Challenges and Competition - The company faces significant competition in both robotics and autonomous driving, with rivals like Waymo and Baidu expanding their services [5]. - Tesla is also planning to establish a large-scale chip manufacturing facility, TeraFab, to ensure it can meet its hardware needs and mitigate geopolitical risks [6]. Group 4: Expansion of Services - Tesla aims to expand its Robotaxi fleet in the U.S. and is testing a fully autonomous ride-hailing service in Austin, Texas, with plans to extend this service to seven additional markets [4].

当前，在政策引领、技术突破与市场需求的共振驱动下，中国具身智能产业正迈入快速发展的新阶段。在此背景下，资本市场布局也日益活跃。公开资料 数据显示，2025年前11个月具身智能产业融资额达到334.73亿元，是2024年同期的4倍；截至2025年12月21日，全年融资事件超305起，总额超过380亿 元，参与的投资机构数量超过600家。资本的密集涌入，充分印证了产业发展的潜力与市场信心。这种信心，根植于社会经济发展中持续涌现的明确而迫 切的替代需求。随着人口老龄化加剧与劳动力结构性短缺等问题持续凸显，社会对能够替代人工、承担高风险任务并提升产线效率的智能化解决方案需求 日益迫切。传统自动化设备受限于固定场景与预设程序，难以适应柔性制造、人机协作等动态复杂环境，产业升级面临核心瓶颈。为突破这一局限，以人 形机器人为代表的具身智能正在加速演进，逐步形成具备高阶认知能力的"感知-认知-决策-执行"完整技术闭环，并逐步走向规模化量产，以更好地适应多 样化场景需求。由此，具身智能产业的发展主线已从技术攻关延伸至生态构建与商业闭环，标志着产业正式进入价值兑现的关键阶段。 中国具身智能产业已凭借综合优势跻身全球第一梯队 从技 ...

Core Viewpoint - Shanghai is set to achieve a GDP of 5.67 trillion yuan by 2025, reflecting a year-on-year growth of 5.4%, as it aims to enhance its role as an international technology innovation center [3]. Economic Growth and Structure - Over the past five years, Shanghai's economy has surpassed the 5 trillion yuan mark, adding over 1 trillion yuan, equivalent to creating a new "trillion-level city" [3]. - The city is focusing on enhancing its economic structure and quality during the 14th Five-Year Plan period, aiming for a new phase of development [3][4]. Key Industries and Innovations - Shanghai's leading industries, including integrated circuits, artificial intelligence, and biomedicine, are projected to see significant growth. The integrated circuit industry is expected to generate over 488 billion yuan in revenue by 2025, doubling in size over five years [5]. - The artificial intelligence sector is anticipated to exceed 550 billion yuan, with a year-on-year growth rate of over 30% [5]. - By 2025, Shanghai's three leading industries are expected to achieve an industrial output value growth of 9.6%, surpassing 2 trillion yuan for the first time [5]. Investment and Business Environment - Shanghai has seen an average of over 5,800 new foreign-funded enterprises established annually since the 14th Five-Year Plan, reinforcing its position as a major global trade hub [21]. - The city has implemented various measures to optimize its investment environment, including policies to support foreign R&D centers and enhance their capabilities [24]. Export and Trade Performance - In 2025, Shanghai's total import and export volume is expected to exceed 3 trillion USD over five years, with exports growing significantly, including a 10.8% increase in overall exports [26]. - The export of high-end machine tools, industrial robots, and electric vehicles has seen substantial growth, with industrial robots' exports increasing by over 40% [26]. Regional Development and Innovation - The Pudong New Area, accounting for one-third of Shanghai's economic output, is focusing on upgrading its industrial structure and fostering innovation [12][14]. - The area is actively reducing low-end capacity while promoting the rapid development of core industrial clusters [14][15].

《科创板日报》1月29日讯（记者 吴旭光） 1月29日盘后，绿的谐波发布公告称，公司预计2025年归属于上市公司股 东的净利润为1.15亿元-1.30亿元，同比增长104.74%-131.45%。 据此计算，该公司2025年Q4净利预计0.21亿元-0.36亿元，同比增长900.55%至1463.45%，环比下降9%至47%。** "要推动具身智能真正落地应用，行业还需共同突破当下普遍存在的技术难题。"今日（1月29日），中国城市发展研 究院投资部副主任袁帅在接受《科创板日报》记者采访时表示，后续的核心发力点，在于提升机器人的"大脑"运算能 力与实际操作水平。其认为，若机器人无法具备接近人类的操作效率，那么其最终只会沦为观赏性的"花瓶"，难以发 挥实际价值。 与此同时，在袁帅看来，在工业领域，机器人的效率高低与柔性表现，会直接决定用户是否愿意采纳，那些可即插即 用、高效便捷的机器人，未来将在生产线中占据重要地位、发挥关键作用。 二级市场表现方面，截至1月29日收盘，绿的谐波股价报212.46元/股，公司总市值为389.50亿元。 对于业绩变化，绿的谐波表示，2025年公司业绩实现显著增长，核心得益于多方面有利 ...